PYLARIFY Trademark

Trademark Overview

On Tuesday, October 8, 2019, a trademark application was filed for PYLARIFY with the United States Patent and Trademark Office. The USPTO has given the PYLARIFY trademark a serial number of 88647018. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by Progenics Pharmaceuticals, Inc.. The PYLARIFY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services

Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer
pylarify

General Information

Serial Number88647018
Word MarkPYLARIFY
Filing DateTuesday, October 8, 2019
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7075521
Registration DateTuesday, June 6, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and ServicesProviding medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services
Goods and ServicesScientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 15, 2019
Primary Code042
First Use Anywhere DateTuesday, February 22, 2022
First Use In Commerce DateTuesday, February 22, 2022
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 15, 2019
Primary Code044
First Use Anywhere DateTuesday, February 22, 2022
First Use In Commerce DateTuesday, February 22, 2022

Trademark Owner History

Party NameProgenics Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameProgenics Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameProgenics Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Trademark Events

Event DateEvent Description
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, April 29, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, April 28, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, April 17, 2023USE AMENDMENT FILED
Monday, April 17, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, October 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 30, 2022SOU EXTENSION 5 GRANTED
Wednesday, September 28, 2022SOU EXTENSION 5 FILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2022SOU EXTENSION 4 GRANTED
Monday, March 28, 2022SOU EXTENSION 4 FILED
Monday, March 28, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 21, 2021SOU EXTENSION 3 GRANTED
Tuesday, September 21, 2021SOU EXTENSION 3 FILED
Tuesday, September 21, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 9, 2021SOU EXTENSION 2 GRANTED
Friday, April 9, 2021SOU EXTENSION 2 FILED
Friday, April 9, 2021SOU TEAS EXTENSION RECEIVED
Thursday, December 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020CORRECTED NOA E-MAILED
Wednesday, July 1, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 1 FILED
Wednesday, July 1, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, June 17, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, July 1, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 17, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, June 17, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020ASSIGNED TO LIE
Friday, January 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 17, 2020EXAMINER'S AMENDMENT ENTERED
Friday, January 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 17, 2020EXAMINERS AMENDMENT E-MAILED
Friday, January 17, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, January 13, 2020ASSIGNED TO EXAMINER
Tuesday, October 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 11, 2019NEW APPLICATION ENTERED

Related Keywords

pylarify medical cancer treatment identification providing imaging diagnosis prevention field information